Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Daniel Grasso

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-8932-716X; OpenAlex author ID A5053064064. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 5 papers

Papers 13

  1. Type I interferons modulate autophagy to shape gemcitabine response in pancreatic cancer cells. Co-author DOI 10.1002/2211-5463.70342↗
  2. When defense turns dangerous: The dual nature of senescence in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.critrevonc.2026.105328↗
  3. Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. Co-author DOI 10.1016/j.isci.2026.115164↗
  4. Pathway-driven therapeutic stratification in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.tranon.2026.102920↗
  5. Small CD63 + CD81+ extracellular vesicles induce autophagy via the FOXO3a pathway in pancreatic cancer cells during starvation. Co-author DOI 10.1038/s41598-026-52731-0↗
  6. KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2025.102421↗
  7. SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer. Co-author DOI 10.1042/bcj20220439↗
  8. [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. Co-author PMID 37582144↗
  9. Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer. Co-author DOI 10.3390/molecules27113492↗
  10. Autophagy-Mediated Exosomes as Immunomodulators of Natural Killer Cells in Pancreatic Cancer Microenvironment. Co-author DOI 10.3389/fonc.2020.622956↗
  11. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation. First author DOI 10.1172/jci76037↗
  12. NUPR1 works against the metabolic stress-induced autophagy-associated cell death in pancreatic cancer cells. Co-author DOI 10.4161/auto.22258↗
  13. Autophagy in pancreatic cancer. Co-author DOI 10.1155/2012/760498↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. María Noé Garcia · 10 shared papers, 2012–2026 · strength 1.62
  2. Daniela Laura Papademetrio · 7 shared papers, 2020–2026 · strength 1.49
  3. Juan Iovanna · 8 shared papers, 2012–2026 · strength 1.44
  4. Nelson Dusetti · 5 shared papers, 2023–2026 · strength 1.31
  5. Nicolas Alejandro Fraunhoffer · 4 shared papers, 2023–2026 · strength 0.81
  6. Eduardo Chuluyán · 4 shared papers, 2023–2026 · strength 0.81
  7. Élida Álvarez · 3 shared papers, 2020–2026 · strength 0.74
  8. Oscar Mazza · 3 shared papers, 2023–2026 · strength 0.57
  9. María Eugenia Pasqualini · 3 shared papers, 2023–2026 · strength 0.57
  10. Agustín Yaneff · 3 shared papers, 2023–2026 · strength 0.57
  11. Analía Meilerman Abuelafia · 2 shared papers, 2025–2026 · strength 0.45
  12. Jonathan Garnier · 2 shared papers, 2026 · strength 0.42
  13. Brice Chanez · 2 shared papers, 2026 · strength 0.42
  14. Patricia Santofimia‐Castaño · 2 shared papers, 2023–2025 · strength 0.39
  15. Ana Sahores · 2 shared papers, 2023–2026 · strength 0.35
  16. Raul A. Urrutia · 3 shared papers, 2013–2025 · strength 0.32
  17. Gwen Alyce Lomberk · 3 shared papers, 2013–2025 · strength 0.32
  18. Lucy Elena Bonilla · 1 shared paper, 2026 · strength 0.28
  19. Matías Estarás · 1 shared paper, 2025 · strength 0.25
  20. Pascal R. Hammel · 1 shared paper, 2026 · strength 0.21
  21. Nadia Talin Mirakian · 1 shared paper, 2022 · strength 0.19
  22. Laura Cecilia Laurella · 1 shared paper, 2022 · strength 0.19
  23. Brooke D. Paradise · 1 shared paper, 2023 · strength 0.16
  24. Renzo Emanuel Vera · 1 shared paper, 2023 · strength 0.16
  25. Glancis L. Raja Arul · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.